Carolyn Ruth Rogers-Vizena, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cleft Lip | 15 | 2023 | 512 | 4.550 |
Why?
|
Cleft Palate | 11 | 2023 | 596 | 2.580 |
Why?
|
Surgery, Plastic | 5 | 2024 | 652 | 1.320 |
Why?
|
Surgical Flaps | 6 | 2023 | 1682 | 1.140 |
Why?
|
Ketorolac | 2 | 2024 | 95 | 1.060 |
Why?
|
Lip | 5 | 2023 | 196 | 1.000 |
Why?
|
Rhytidoplasty | 2 | 2015 | 72 | 0.930 |
Why?
|
Facial Neoplasms | 2 | 2015 | 126 | 0.920 |
Why?
|
Facial Muscles | 5 | 2016 | 159 | 0.870 |
Why?
|
Mammaplasty | 2 | 2024 | 1268 | 0.800 |
Why?
|
Velopharyngeal Insufficiency | 1 | 2023 | 103 | 0.780 |
Why?
|
DiGeorge Syndrome | 1 | 2023 | 187 | 0.760 |
Why?
|
Gynecomastia | 1 | 2022 | 88 | 0.750 |
Why?
|
Pharynx | 1 | 2023 | 436 | 0.710 |
Why?
|
Skin Transplantation | 3 | 2015 | 1096 | 0.690 |
Why?
|
Breast Neoplasms, Male | 1 | 2022 | 213 | 0.690 |
Why?
|
Internship and Residency | 5 | 2024 | 5953 | 0.680 |
Why?
|
Incidental Findings | 2 | 2022 | 698 | 0.650 |
Why?
|
Pierre Robin Syndrome | 2 | 2019 | 118 | 0.600 |
Why?
|
Mastectomy | 2 | 2024 | 1861 | 0.560 |
Why?
|
Orthognathic Surgical Procedures | 1 | 2018 | 120 | 0.550 |
Why?
|
Craniofacial Dysostosis | 1 | 2016 | 74 | 0.530 |
Why?
|
Models, Anatomic | 2 | 2018 | 680 | 0.530 |
Why?
|
Ectodermal Dysplasia | 1 | 2016 | 107 | 0.490 |
Why?
|
Tissue Expansion | 1 | 2016 | 163 | 0.480 |
Why?
|
Osteogenesis, Distraction | 1 | 2016 | 233 | 0.440 |
Why?
|
Tissue and Organ Harvesting | 1 | 2016 | 373 | 0.420 |
Why?
|
Breast | 1 | 2021 | 1976 | 0.390 |
Why?
|
Skull | 1 | 2016 | 820 | 0.380 |
Why?
|
Bone Transplantation | 1 | 2016 | 925 | 0.370 |
Why?
|
Skin Neoplasms | 3 | 2015 | 5863 | 0.350 |
Why?
|
Prenatal Diagnosis | 1 | 2016 | 1275 | 0.320 |
Why?
|
Nose Neoplasms | 1 | 2011 | 250 | 0.310 |
Why?
|
Pan troglodytes | 1 | 2009 | 224 | 0.310 |
Why?
|
Mohs Surgery | 1 | 2011 | 217 | 0.300 |
Why?
|
Biological Evolution | 2 | 2016 | 1076 | 0.300 |
Why?
|
Personnel Selection | 1 | 2009 | 201 | 0.280 |
Why?
|
Carcinoma, Basal Cell | 1 | 2011 | 565 | 0.250 |
Why?
|
Nose | 2 | 2022 | 522 | 0.240 |
Why?
|
Mouth | 1 | 2007 | 383 | 0.240 |
Why?
|
Neuromuscular Agents | 1 | 2007 | 148 | 0.240 |
Why?
|
Retrospective Studies | 14 | 2024 | 81762 | 0.240 |
Why?
|
Education, Medical, Graduate | 3 | 2024 | 2420 | 0.240 |
Why?
|
Computer Simulation | 3 | 2022 | 6283 | 0.220 |
Why?
|
Botulinum Toxins, Type A | 1 | 2007 | 238 | 0.210 |
Why?
|
Clinical Competence | 3 | 2024 | 4858 | 0.210 |
Why?
|
Facial Paralysis | 1 | 2007 | 346 | 0.200 |
Why?
|
Face | 2 | 2020 | 1029 | 0.200 |
Why?
|
Esthetics | 1 | 2023 | 328 | 0.190 |
Why?
|
Animals, Domestic | 1 | 2020 | 56 | 0.180 |
Why?
|
Humans | 38 | 2024 | 768166 | 0.180 |
Why?
|
Narcotics | 1 | 2022 | 332 | 0.170 |
Why?
|
Horses | 1 | 2020 | 295 | 0.170 |
Why?
|
Hematoma | 1 | 2024 | 766 | 0.160 |
Why?
|
Cats | 1 | 2020 | 978 | 0.160 |
Why?
|
Child | 9 | 2023 | 80917 | 0.160 |
Why?
|
Postoperative Complications | 4 | 2024 | 15832 | 0.150 |
Why?
|
Hyperplasia | 1 | 2021 | 1151 | 0.150 |
Why?
|
Curriculum | 2 | 2021 | 3782 | 0.140 |
Why?
|
Printing | 1 | 2017 | 47 | 0.140 |
Why?
|
Orbital Fractures | 1 | 2017 | 108 | 0.130 |
Why?
|
Osteotomy, Le Fort | 1 | 2016 | 94 | 0.130 |
Why?
|
Dogs | 1 | 2020 | 3845 | 0.120 |
Why?
|
Nasal Septum | 1 | 2016 | 131 | 0.120 |
Why?
|
Anesthetics, Local | 1 | 2022 | 1005 | 0.120 |
Why?
|
Analgesics | 1 | 2022 | 1071 | 0.120 |
Why?
|
Computer-Aided Design | 1 | 2017 | 294 | 0.120 |
Why?
|
Forehead | 1 | 2015 | 75 | 0.120 |
Why?
|
Muscle Fibers, Skeletal | 2 | 2009 | 553 | 0.120 |
Why?
|
Airway Obstruction | 1 | 2019 | 672 | 0.120 |
Why?
|
Dexamethasone | 1 | 2022 | 1965 | 0.120 |
Why?
|
Nausea | 1 | 2017 | 682 | 0.120 |
Why?
|
Vomiting | 1 | 2017 | 655 | 0.110 |
Why?
|
Primates | 1 | 2016 | 520 | 0.110 |
Why?
|
Breast Neoplasms | 1 | 2021 | 21206 | 0.110 |
Why?
|
Pregnancy Trimester, Second | 1 | 2016 | 737 | 0.110 |
Why?
|
Scalp | 1 | 2016 | 391 | 0.110 |
Why?
|
Adolescent | 7 | 2023 | 89169 | 0.110 |
Why?
|
Mandible | 2 | 2008 | 754 | 0.100 |
Why?
|
Female | 17 | 2024 | 397192 | 0.100 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2011 | 9419 | 0.100 |
Why?
|
Blood Loss, Surgical | 1 | 2016 | 642 | 0.100 |
Why?
|
Pain, Postoperative | 1 | 2022 | 1765 | 0.100 |
Why?
|
Movement | 1 | 2018 | 1490 | 0.090 |
Why?
|
Curettage | 1 | 2011 | 74 | 0.090 |
Why?
|
Mouth Mucosa | 1 | 2014 | 435 | 0.090 |
Why?
|
Risk Factors | 3 | 2024 | 74944 | 0.090 |
Why?
|
Magnetic Resonance Imaging | 2 | 2016 | 36743 | 0.090 |
Why?
|
Male | 14 | 2023 | 364719 | 0.090 |
Why?
|
Rhinoplasty | 1 | 2014 | 241 | 0.090 |
Why?
|
Cryotherapy | 1 | 2011 | 164 | 0.090 |
Why?
|
Abnormalities, Multiple | 1 | 2016 | 1424 | 0.080 |
Why?
|
Mouth Floor | 1 | 2008 | 39 | 0.080 |
Why?
|
Child, Preschool | 3 | 2023 | 42669 | 0.080 |
Why?
|
Speech | 2 | 2023 | 557 | 0.080 |
Why?
|
Young Adult | 4 | 2023 | 60066 | 0.070 |
Why?
|
Age Factors | 2 | 2023 | 18412 | 0.070 |
Why?
|
Multivariate Analysis | 1 | 2021 | 12077 | 0.070 |
Why?
|
Health Personnel | 1 | 2021 | 3385 | 0.070 |
Why?
|
Facial Asymmetry | 1 | 2007 | 173 | 0.070 |
Why?
|
Dissection | 1 | 2007 | 299 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2022 | 3837 | 0.060 |
Why?
|
Mandibular Neoplasms | 1 | 2006 | 131 | 0.060 |
Why?
|
Antibiotic Prophylaxis | 1 | 2011 | 640 | 0.060 |
Why?
|
Boston | 1 | 2018 | 9374 | 0.060 |
Why?
|
Treatment Outcome | 4 | 2023 | 65371 | 0.060 |
Why?
|
Connective Tissue | 1 | 2007 | 425 | 0.060 |
Why?
|
Feedback | 1 | 2009 | 799 | 0.060 |
Why?
|
Pregnancy Outcome | 1 | 2016 | 2972 | 0.060 |
Why?
|
Coloring Agents | 1 | 2007 | 565 | 0.060 |
Why?
|
Facial Expression | 1 | 2009 | 515 | 0.060 |
Why?
|
Oral Surgical Procedures | 1 | 2006 | 172 | 0.060 |
Why?
|
Dinoflagellida | 1 | 2004 | 9 | 0.060 |
Why?
|
Chloroplasts | 1 | 2004 | 46 | 0.060 |
Why?
|
Prospective Studies | 3 | 2023 | 54926 | 0.060 |
Why?
|
Wound Healing | 1 | 2015 | 2809 | 0.060 |
Why?
|
Phenotype | 2 | 2020 | 16726 | 0.060 |
Why?
|
Genes, Protozoan | 1 | 2004 | 170 | 0.060 |
Why?
|
Expressed Sequence Tags | 1 | 2004 | 251 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 1 | 2017 | 4063 | 0.050 |
Why?
|
Cadaver | 1 | 2007 | 1363 | 0.050 |
Why?
|
Cost-Benefit Analysis | 1 | 2016 | 5536 | 0.050 |
Why?
|
Reoperation | 1 | 2014 | 4329 | 0.050 |
Why?
|
Pilot Projects | 1 | 2016 | 8741 | 0.050 |
Why?
|
Speech Disorders | 1 | 2023 | 179 | 0.050 |
Why?
|
Career Choice | 1 | 2009 | 769 | 0.050 |
Why?
|
Adult | 5 | 2022 | 223646 | 0.050 |
Why?
|
Preoperative Care | 1 | 2011 | 2258 | 0.050 |
Why?
|
Interviews as Topic | 1 | 2009 | 2741 | 0.050 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14729 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2016 | 13014 | 0.050 |
Why?
|
Infant | 3 | 2019 | 36535 | 0.040 |
Why?
|
Infant, Newborn | 2 | 2019 | 26422 | 0.040 |
Why?
|
Data Collection | 1 | 2009 | 3327 | 0.040 |
Why?
|
Fluorescent Dyes | 1 | 2007 | 1930 | 0.040 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7454 | 0.040 |
Why?
|
Africa, Northern | 1 | 2018 | 86 | 0.040 |
Why?
|
Evidence-Based Medicine | 1 | 2011 | 3706 | 0.040 |
Why?
|
Middle East | 1 | 2018 | 233 | 0.040 |
Why?
|
Glossectomy | 2 | 2008 | 60 | 0.040 |
Why?
|
Ultrasonography | 2 | 2007 | 6004 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2016 | 39348 | 0.030 |
Why?
|
Melanoma | 1 | 2015 | 5706 | 0.030 |
Why?
|
Airway Management | 1 | 2019 | 326 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2017 | 20760 | 0.030 |
Why?
|
Diplopia | 1 | 2017 | 217 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2004 | 2885 | 0.030 |
Why?
|
Pregnancy | 1 | 2016 | 30256 | 0.030 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2007 | 3390 | 0.030 |
Why?
|
Aged | 5 | 2011 | 171504 | 0.030 |
Why?
|
Interpersonal Relations | 1 | 2020 | 1434 | 0.030 |
Why?
|
Otolaryngology | 1 | 2019 | 699 | 0.030 |
Why?
|
Psychometrics | 1 | 2020 | 3063 | 0.020 |
Why?
|
Quality of Life | 2 | 2023 | 13490 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2023 | 26379 | 0.020 |
Why?
|
Consensus | 1 | 2019 | 3212 | 0.020 |
Why?
|
Qualitative Research | 1 | 2021 | 3140 | 0.020 |
Why?
|
Sex Factors | 1 | 2023 | 10632 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2020 | 3488 | 0.020 |
Why?
|
Animals | 4 | 2020 | 169246 | 0.020 |
Why?
|
Parents | 1 | 2020 | 3595 | 0.020 |
Why?
|
Developing Countries | 1 | 2018 | 2910 | 0.020 |
Why?
|
Fibula | 1 | 2008 | 270 | 0.020 |
Why?
|
Middle Aged | 4 | 2008 | 223492 | 0.020 |
Why?
|
Bone Plates | 1 | 2006 | 468 | 0.010 |
Why?
|
DNA, Protozoan | 1 | 2004 | 227 | 0.010 |
Why?
|
Microsurgery | 1 | 2008 | 800 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2020 | 20227 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2007 | 59629 | 0.010 |
Why?
|
Gene Library | 1 | 2004 | 1064 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15454 | 0.010 |
Why?
|
United States | 1 | 2009 | 73039 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2004 | 1989 | 0.010 |
Why?
|
Recombination, Genetic | 1 | 2004 | 1525 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2007 | 2650 | 0.010 |
Why?
|
Evolution, Molecular | 1 | 2004 | 1896 | 0.010 |
Why?
|
Head and Neck Neoplasms | 1 | 2008 | 2931 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2004 | 4786 | 0.010 |
Why?
|
Comorbidity | 1 | 2006 | 10590 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2004 | 17622 | 0.010 |
Why?
|
Genomics | 1 | 2004 | 5926 | 0.000 |
Why?
|
Algorithms | 1 | 2008 | 14164 | 0.000 |
Why?
|
Prognosis | 1 | 2006 | 30010 | 0.000 |
Why?
|